ArticleNature communications2024

MMP-2-triggered, mitochondria-targeted PROTAC-PDT therapy of breast cancer and brain metastases inhibition.

Fan Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.